<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: lipoprotein</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Low cholesterol transfer protein activity associated with heart disease risk</title>
   	 <description> Although seen as a potential heart disease therapy, raising high-density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests. Scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University  and Boston University School of Medicine found an association between low plasma cholesterol ester transfer protein (CETP) activity and increased risk of heart disease in the Framingham Heart Study population.</description>
     <link>http://www.physorg.com/news180096318.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 15 Dec 2009 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news180096318</guid>
</item>
<item>
     <title>Genetic analysis helps dissect molecular basis of cardiovascular disease</title>
   	 <description>Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study. </description>
     <link>http://www.physorg.com/news177945626.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 20 Nov 2009 13:40:10 EST</pubDate>
	 <guid isPermaLink="false">news177945626</guid>
</item>
<item>
     <title>Prevalence of high LDL, or 'bad' cholesterol levels decreases in US</title>
   	 <description>Between 1999 and 2006, the prevalence of adults in the U.S. with high levels of LDL cholesterol, the "bad" cholesterol, decreased by about one-third, according to a study in the November 18 issue of JAMA. But a high percentage of adults still are not being screened or treated for high cholesterol levels. </description>
     <link>http://www.physorg.com/news177703506.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 18:40:03 EST</pubDate>
	 <guid isPermaLink="false">news177703506</guid>
</item>
<item>
     <title>Increased obesity hindering success at reducing heart disease risk</title>
   	 <description>The dramatic increase in overweight and obesity in adult Americans over the past 20 years has undermined public health success at reducing risk for heart disease, according to research presented at the American Heart Association's Scientific Sessions 2009.</description>
     <link>http://www.physorg.com/news177690584.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 14:40:02 EST</pubDate>
	 <guid isPermaLink="false">news177690584</guid>
</item>
<item>
     <title>No need to fast for cholesterol test</title>
   	 <description>(PhysOrg.com) -- Patients do not need to fast before having their cholesterol tested, a major study has found.</description>
     <link>http://www.physorg.com/news177338824.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 13 Nov 2009 13:06:15 EST</pubDate>
	 <guid isPermaLink="false">news177338824</guid>
</item>
<item>
     <title>Adding ezetimibe to atorvastatin improves lipid control</title>
   	 <description>Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.</description>
     <link>http://www.physorg.com/news175847051.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 27 Oct 2009 07:25:38 EST</pubDate>
	 <guid isPermaLink="false">news175847051</guid>
</item>
<item>
     <title>Metabolic syndrome linked to liver disease in obese teenaged boys</title>
   	 <description>Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.</description>
     <link>http://www.physorg.com/news173459901.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 29 Sep 2009 16:30:07 EST</pubDate>
	 <guid isPermaLink="false">news173459901</guid>
</item>
<item>
     <title>Little known type of cholesterol may pose the greatest heart disease risk</title>
   	 <description>Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol  - virtually unknown to the public  - may be the most serious cardiovascular health threat of all.</description>
     <link>http://www.physorg.com/news169978803.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 Aug 2009 09:20:51 EST</pubDate>
	 <guid isPermaLink="false">news169978803</guid>
</item>
<item>
     <title>Obesity is a poor gauge for detecting high cholesterol levels in children</title>
   	 <description>With the epidemic of childhood obesity in the United States, there is concern that overweight and obese children need to be screened for chronic medical conditions, including high cholesterol levels.</description>
     <link>http://www.physorg.com/news168538390.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 20:20:05 EST</pubDate>
	 <guid isPermaLink="false">news168538390</guid>
</item>
<item>
     <title>Weight loss improves mood in depressed people</title>
   	 <description>Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds that after a 6-month behavioral weight loss program, depressed patients not only lost 8% of their initial weight but also reported significant improvements in their symptoms of depression, as well as reductions in triglycerides, which are a risk factor for heart disease and stroke. The results of this study highlight the need for further research into the effects of weight loss in individuals suffering from psychiatric disorders.</description>
     <link>http://www.physorg.com/news167907081.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Jul 2009 09:51:46 EST</pubDate>
	 <guid isPermaLink="false">news167907081</guid>
</item>
<item>
     <title>Newly discovered gene regulates balance of 'bad' cholesterol </title>
   	 <description>In an article in Science, Noam Zelcer from the LACDR (The Netherlands) describes a previously unknown mechanism for regulating the amount of LDL cholesterol. This offers opportunities for supplementing and improving the effect of so-called statins: medicines that remove 'bad' cholesterol from the bloodstream. </description>
     <link>http://www.physorg.com/news165739143.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Jul 2009 07:39:41 EST</pubDate>
	 <guid isPermaLink="false">news165739143</guid>
</item>
<item>
     <title>Genetically elevated levels of lipoprotein associated with increased risk of heart attack</title>
   	 <description>A genetic analysis of data from three studies suggests that genetically elevated levels of lipoprotein(a) are associated with an increased risk of heart attack, according to a study in the June 10 issue of JAMA. </description>
     <link>http://www.physorg.com/news163823424.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 03:31:13 EST</pubDate>
	 <guid isPermaLink="false">news163823424</guid>
</item>
<item>
     <title>New research suggests common anti-seizure medications may increase risk of cardiovascular problems</title>
   	 <description>An important clinical repercussion in the treatment of epilepsy has been discovered by a research team led by Scott Mintzer, M.D., assistant professor in the Department of Neurology and the Jefferson Comprehensive Epilepsy Center at Jefferson Medical College of Thomas Jefferson University.  The team has determined that two of the most commonly prescribed anti-seizure medications may lead to significantly increased levels of cholesterol, C-reactive protein and other markers of cardiovascular disease risk.  The finding - set to be published in the March 18th online edition of Annals of Neurology - may help doctors manage the care of patients with seizures more effectively by prescribing different anti-seizure medications that will not adversely affect cardiovascular health.</description>
     <link>http://www.physorg.com/news156607822.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Mar 2009 15:10:54 EST</pubDate>
	 <guid isPermaLink="false">news156607822</guid>
</item>
<item>
     <title>Cholesterol-reducing drugs may lessen brain function</title>
   	 <description>Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.</description>
     <link>http://www.physorg.com/news154632233.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Feb 2009 17:24:26 EST</pubDate>
	 <guid isPermaLink="false">news154632233</guid>
</item>
<item>
     <title>Most heart attack patients' cholesterol levels did not indicate cardiac risk</title>
   	 <description>A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event, according to current national cholesterol guidelines.</description>
     <link>http://www.physorg.com/news150990512.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Jan 2009 13:48:32 EST</pubDate>
	 <guid isPermaLink="false">news150990512</guid>
</item>
<item>
     <title>Apolipoprotein(a): A natural regulator of inflammation</title>
   	 <description>In a study to be published in the January 09 issue of Experimental Biology and Medicine, Hoover-Plow and co-workers in seeking to define a role of apo(a) in leukocyte recruitment have identified a novel activity of apo(a) apolipoprotein that may function as a natural and cell specific suppressor of the inflammatory response in vivo. In addition, a mechanism for this novel function of apo(a) was also identified: its selective regulation of cytokine production. These effects of apo(a) are independent of its molecular mimicry of Plg.</description>
     <link>http://www.physorg.com/news149345421.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 24 Dec 2008 12:50:21 EST</pubDate>
	 <guid isPermaLink="false">news149345421</guid>
</item>


</channel>
</rss>

